Personalized approaches for treatment-naïve mantle cell lymphoma.

Published in: Expert review of hematology (2023)

Given the wide array of disease and patient presentations with MCL, a personalized therapeutic approach is needed to optimize outcomes. The best therapeutic strategy should incorporate disease prognostic factors, patient status and comorbidities, goals of care, and response to treatment.

Keyphrases

prognostic factors
healthcare
case report
palliative care
high resolution
type diabetes
high throughput
combination therapy
metabolic syndrome
replacement therapy
skeletal muscle